Hercules Capital, Inc. (HTGC) 2018 10-K Summary
Business Context and Reporting Period
Company: Hercules Capital, Inc. (HTGC)
Reporting Period: Fiscal year ended December 31, 2018
Business Model: An internally managed, non-diversified closed-end investment company regulated as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company focuses on providing senior secured loans, structured debt with warrants, and equity investments to high-growth, venture capital-backed companies in technology, life sciences, and sustainable/renewable technology sectors.
Key Financial Metrics (Year Ended Dec 31, 2018)
- Net Investment Income: $108.7 million (up from $96.4 million in 2017).
- Total Investment Income: $207.8 million (Interest: $190.6 million; Fees: $17.1 million).
- Net Realized Gain/Loss: $(11.1) million loss (vs. $(26.7) million loss in 2017).
- Net Unrealized Appreciation/Depreciation: $(21.1) million depreciation (vs. $9.3 million appreciation in 2017).
- Net Increase in Net Assets from Operations: $76.5 million.
- Earnings Per Share (Basic & Diluted): $0.83.
- Net Asset Value (NAV) per Share: $9.90 (down from $9.96 in 2017).
- Total Assets: $1.95 billion.
- Total Debt Investments (at value): $1.73 billion.
- Weighted Average Cost of Debt: 5.6% (down from 5.9% in 2017).
- Asset Coverage Ratio: 214.6% (excluding SBA debentures); 197.2% (including SBA debentures).
- Liquidity: $156.2 million available (including $34.2 million cash and $122.1 million in credit facility capacity).
Material Changes vs. Prior Period
- Portfolio Growth: Total investment portfolio value increased to $1.88 billion from $1.54 billion in 2017, driven by new fundings of $960.7 million.
- Unrealized Depreciation: The company recorded $21.1 million in net unrealized depreciation, a reversal from the $9.3 million appreciation in 2017. This was primarily due to $17.1 million in collateral-based impairments on the debt portfolio and $24.8 million in depreciation on equity investments.
- Realized Losses: Net realized losses improved to $11.1 million from $26.7 million in 2017, though gross realized losses remained significant at $25.1 million due to write-offs and liquidations.
- Debt Structure: The company issued $200.0 million in 2027 Asset-Backed Notes, $75.0 million in 2025 Notes, and $40.0 million in 2033 Notes. It also fully redeemed the 2021 Asset-Backed Notes and partially redeemed 2024 Notes.
- Regulatory Change: Effective December 7, 2018, the company adopted the 150% minimum asset coverage ratio (down from 200%) permitted by the Small Business Credit Availability Act, allowing for increased leverage capacity.
Guidance, Outlook, and Risks
- Outlook: Management expects to continue originating investments in technology-related industries. The company maintains a variable distribution policy targeting 90-100% of taxable income.
- Distributions: A cash distribution of $0.31 per share was declared on February 13, 2019. The company intends to distribute 100% of spillover earnings from 2018 in 2019.
- Capital Markets: The company has an active At-The-Market (ATM) equity program with 5.3 million shares remaining available. A $25.0 million stock repurchase plan was authorized in December 2018, with $20.9 million remaining as of year-end.
- Risks:
- Concentration: 87.8% of the portfolio is concentrated in five industries (Software, Drug Discovery, Internet Services, Medical Devices, Renewable Tech).
- Valuation Uncertainty: 96.7% of assets are Level 3 investments valued in good faith by the Board, creating potential volatility in NAV.
- Leverage: Increased leverage capacity under the new 150% asset coverage rule increases risk exposure.
- Interest Rates: 97.3% of the loan portfolio is floating rate; rising rates increase income but also borrower default risk.
Key Facts for Investor Verification
- NAV Decline: Verify the drivers of the $21.1 million unrealized depreciation, specifically the $17.1 million in collateral-based impairments on debt investments.
- Realized Losses: Review the specific portfolio companies contributing to the $25.1 million in gross realized losses to assess credit quality trends.
- Debt Maturities: Confirm the repayment schedule for the $980.5 million in outstanding debt, noting the maturity of credit facilities in 2023 and the 2022 Convertible Notes.
- Unfunded Commitments: Assess the $139.0 million in unfunded commitments and the company's liquidity position to fund these obligations.
- Regulatory Compliance: Monitor the company's ability to maintain RIC status given the mix of cash and non-cash (PIK/OID) income requiring distributions.